CIK 0000948320
- Accelerated filer
LifeMD, Inc.
Sign in to watch- Ticker
- LFMD
- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760238453
- Phone
- +1 866-351-5907
- Business address
- 236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
- Former names
- CONVERSION LABS, INC., Immudyne, Inc.
Securities
- LFMD Common Stock Nasdaq
- LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
- 4 Open-market buy Chief Business Officer bought 12,000 shares at $6.82 ($81,799)
- 4 Open-market buy Chief Financial Officer bought 3,067 shares at an average $7.27 ($22,286)
- 4 Derivatives Options or other derivatives
- 4 Gift CEO gave 20,000 shares (gift)
- 4 Open-market buy Chief Business Officer bought 30,000 shares at $12.31 ($369,300)
- 4 Open-market buy Chief Business Officer bought 22,539 shares at $8.85 ($199,470)
- 4 Open-market buy Director bought 2,000 shares at $10.44 ($20,880)
- 4 Open-market buy Chief Executive Officer bought 3,500 shares at $8.54 ($29,890)
- 4 Open-market buy Chief Technology Officer bought 3,796 shares at $10.40 ($39,478)
- 4 Open-market buy CCO and General Counsel bought 11,100 shares at $9.24 ($102,564)
- 4 Open-market buy Chief Financial Officer bought 1,416 shares at an average $8.91 ($12,610)
- 4 Open-market buy Chief Business Officer bought 22,539 shares at $8.85 ($199,470)
- 4/A Open-market buy Chief Operating Officer bought 5,000 shares at $20.50 ($102,500)
- 3/A Insider 3/A
- 3/A Insider 3/A
- 3/A Insider 3/A
- 4 Option exercise Director acquired 300,000 shares (option exercise)
- 4 Option exercise Former Chief Revenue Officer acquired 87,182 shares (option exercise)
- 4 Other acquisition Director acquired 1,200,000 shares (other)
- 4 Grant or award Director acquired 1,200,000 shares (grant or award)
Page 8 of 12 · 230 filings